World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
56
Citations
37884
World Ranking
2173
National Ranking
1080

Barbara L. Weber publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Barbara L. Weber sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 89 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Barbara L. Weber D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Barbara L. Weber sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 56 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Barbara L. Weber is affiliated with Tango Therapeutics in the United States. Their professional focus and contributions are primarily linked to this organization.

The scientist has been recognized as a Member of the Association of American Physicians, an acknowledgment of professional standing in the medical and research community.

There is no available detailed record of publications, frequent co-authors, or specific research topics to outline further aspects of their scientific work. Similarly, information about main fields, subfields of study, or main topics addressed in research is not documented in the current data.

Given these details, the profile of Barbara L. Weber is centered on their affiliation and awarded membership, providing a professional context without extensive research output or publication specifics.

Best Publications

  • Mutations of the BRAF gene in human cancer

    Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens

  • Patterns of somatic mutation in human cancer genomes

    Christopher Greenman;Philip Stephens;Raffaella Smith;Gillian L. Dalgliesh

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod

  • BRAF and RAS mutations in human lung cancer and melanoma

    Marcia S. Brose;Patricia Volpe;Michael Feldman;Madhu Kumar

  • Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski

  • BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

    Couch Fj;DeShano Ml;Blackwood Ma;Calzone K

  • Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

    Junjie Chen;Daniel P. Silver;Deepika Walpita;Sharon B. Cantor

  • Lung cancer: intragenic ERBB2 kinase mutations in tumours.

    Philip Stephens;Chris Hunter;Graham Bignell;Sarah Edkins

  • Network modeling links breast cancer susceptibility and centrosome dysfunction.

    Miguel Angel Pujana;Jing Dong J Han;Lea M. Starita;Kristen N. Stevens

  • Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the cdk-inhibitor p21waf1/cip1

    K Somasundaram;H Zhang;Y X Zeng;Y Houvras

  • BRCA1 physically associates with p53 and stimulates its transcriptional activity

    Hongbing Zhang;Kumaravel Somasundaram;Yi Peng;Hui Tian

  • Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

    Keith S Hoek;Natalie C Schlegel;Patricia Brafford;Antje Sucker

  • Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer

    Helen Davies;Chris Hunter;Raffaella Smith;Philip Stephens

  • Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1

    Stephen C. Rubin;Ivor Benjamin;Kian Behbakht;Hiroyuki Takahashi

  • Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

    Kapaettu Satyamoorthy;Gang Li;Michelle R. Gerrero;Marcia S. Brose

  • Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

    Lucio H. Castilla;Lucio H. Castilla;Fergus J. Couch;Michael R. Erdos;Kent F. Hoskins

  • Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

    Sofia D. Merajver;Trinh M. Pham;Rosemarie F. Caduff;Martha Chen

  • Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians

    Kent F. Hoskins;Jill E. Stopfer;Kathleen A. Calzone;Sofia D. Merajver

  • The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

    Sandra T. Marquis;Jayant V. Rajan;Anthony Wynshaw-Boris;Junzhe Xu

  • BRCA2 germline mutations in male breast cancer cases and breast cancer families.

    Fergus J. Couch;Linda M. Farid;Michelle L. DeShano;Sean V. Tavtigian

Frequent Co-Authors

Steven A. Narod
Steven A. Narod University of Toronto
Henry T. Lynch
Henry T. Lynch Creighton University
Timothy R. Rebbeck
Timothy R. Rebbeck Harvard University
Katherine L. Nathanson
Katherine L. Nathanson University of Pennsylvania
Judy Garber
Judy Garber Harvard University
Michael R. Stratton
Michael R. Stratton Wellcome Sanger Institute
Olufunmilayo I. Olopade
Olufunmilayo I. Olopade University of Chicago
Claudine Isaacs
Claudine Isaacs Georgetown University
William D. Foulkes
William D. Foulkes McGill University
David E. Goldgar
David E. Goldgar University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens numerous doors for both research and professional practice. For those considering a career pivot or advancement, there are a variety of online pathways that intersect with healthcare and life sciences. Many students and professionals look for accelerated programs, such as the shortest rn to bsn program, to quickly boost their qualifications and enter new roles within the healthcare field.

If you’re already an ADN-prepared nurse aiming higher, options like the adn to fnp bridge programs provide streamlined routes to becoming a Family Nurse Practitioner. Those from non-nursing backgrounds drawn to clinical leadership roles can consider an online direct entry msn for a fast track into nursing practice.

As the demand for online education grows, choosing the right institution is key. Debate often centers on programs such as capella rn to bsn vs chamberlain rn to bsn, each offering unique benefits in cost, flexibility, and career outcomes.

Best Scientists Citing Barbara L. Weber